Orchard Therapeutics plc (NasdaqGS:ORTX) announced that it will receive $7.5 million in equity investment on July 1, 2021. The transaction will include participation from Pharming Group N.V. (ENXTAM:PHARM) and share will be issued at premium.
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |